相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Diastolic Pulmonary Vascular Pressure Gradient A Predictor of Prognosis in Out-of-Proportion Pulmonary Hypertension
Christian Gerges et al.
CHEST (2013)
Hemodynamic Responses to Rapid Saline Loading The Impact of Age, Sex, and Heart Failure
Naoki Fujimoto et al.
CIRCULATION (2013)
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension
Benjamin D. Fox et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Treatment of Non-Group 1 Pulmonary Hypertension: Results of a Survey of Pulmonary Hypertension Centers in the United States
M. E. Pugh et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2012)
Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction A Target of Phosphodiesterase-5 Inhibition in a 1-Year Study
Marco Guazzi et al.
CIRCULATION (2011)
Clinical Characteristics of Pulmonary Hypertension in Patients With Heart Failure and Preserved Ejection Fraction
Thenappan Thenappan et al.
CIRCULATION-HEART FAILURE (2011)
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
CIRCULATION-HEART FAILURE (2010)
Misclassification of Pulmonary Hypertension Due to Reliance on Pulmonary Capillary Wedge Pressure Rather Than Left Ventricular End-Diastolic Pressure
Scott D. Halpern et al.
CHEST (2009)
Association of the Metabolic Syndrome With Pulmonary Venous Hypertension
Ivan M. Robbins et al.
CHEST (2009)
Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2009)
Updated Clinical Classification of Pulmonary Hypertension
Gerald Simonneau et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pulmonary hypertension
Gorev Grubu Uyeleri et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2009)
Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
Xavier Jais et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Clinical and hemodynamic effects of bosentan dose optimization in symptomatic heart failure patients with severe systolic dysfunction, associated with secondary pulmonary hypertension - A multi-center randomized study
Edo Kaluski et al.
CARDIOLOGY (2008)
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension
Gregory D. Lewis et al.
CIRCULATION (2007)
Tezosentan in patients with acute heart failure: Design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS)
JR Teerlink et al.
AMERICAN HEART JOURNAL (2005)
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH):: randomised, double-blind, placebo-controlled trial
I Anand et al.
LANCET (2004)
Screening, early detection, and diagnosis of pulmonary arterial hypertension - ACCP evidence-based clinical practice guidelines
M McGoon et al.
CHEST (2004)
分享论文
